Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer’s patients
UK virus hunting labs seek to bolster global variant network
13 January 2022Vaccine mandate will likely have little impact on health care worker staffing shortage
13 January 2022Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer’s patients
Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer’s disease, a new study finds.
